The/DT University/NNP of/IN Toronto/NNP stepped/VBD deeper/RBR into/IN the/DT contest/NN for/IN Connaught/NNP BioSciences/NNP Inc./NNP by/IN *-1/-NONE- reaching/VBG an/DT unusual/JJ agreement/NN with/IN Ciba-Geigy/NNP Ltd./NNP and/CC Chiron/NNP Corp/NNP ./.
The/DT University/NNP said/VBD 0/-NONE- the/DT two/CD companies/NNS agreed/VBD *-1/-NONE- to/TO spend/VB 25/CD million/CD Canadian/JJ dollars/NNS -LRB-/-LRB- $/$ 21.3/CD million/CD *U*/-NONE- -RRB-/-RRB- over/IN 10/CD years/NNS on/IN research/NN at/IN Canadian/JJ universities/NNS if/IN they/PRP are/VBP successful/JJ in/IN *-2/-NONE- acquiring/VBG the/DT vaccine/NN maker/NN ./.
It/PRP said/VBD 0/-NONE- $/$ 10/CD million/CD *U*/-NONE- would/MD go/VB to/TO the/DT University/NNP of/IN Toronto/NNP ./.
Ciba-Geigy/NNP and/CC Chiron/NNP have/VBP made/VBN a/DT joint/JJ bid/NN of/IN C$/$ 866/CD million/CD *U*/-NONE- for/IN Connaught/NNP ,/, and/CC Institut/NNP Merieux/NNP S.A./NNP of/IN France/NNP has/VBZ made/VBN a/DT rival/JJ bid/NN of/IN C$/$ 942/CD million/CD *U*/-NONE- ./.
The/DT University/NNP is/VBZ seeking/VBG an/DT injunction/NN against/IN the/DT Merieux/NNP bid/NN ,/, *-2/-NONE- arguing/VBG that/IN Connaught/NNP 's/POS predecessor/NN company/NN agreed/VBD in/IN 1972/CD that/IN Connaught/NNP 's/POS ownership/NN would/MD n't/RB be/VB transferred/VBN *-1/-NONE- to/TO foreigners/NNS ./.
The/DT university/NN implied/VBD that/IN it/PRP would/MD drop/VB its/PRP$ opposition/NN to/TO foreign/JJ ownership/NN if/IN Ciba-Geigy/NNP and/CC Chiron/NNP are/VBP successful/JJ with/IN their/PRP$ lower/JJR bid/NN ./.
It/PRP said/VBD 0/-NONE- the/DT new/JJ agreement/NN would/MD ``/`` replace/VB ''/'' the/DT old/JJ one/CD that/WDT *T*-1/-NONE- forms/VBZ the/DT basis/NN of/IN its/PRP$ suit/NN against/IN the/DT Merieux/NNP takeover/NN ./.
``/`` Notwithstanding/IN foreign/JJ ownership/NN of/IN Connaught/NNP ,/, this/DT accord/NN would/MD enhance/VB research/NN and/CC development/NN in/IN Canada/NNP ,/, ''/'' said/VBD *T*-1/-NONE- James/NNP Keffer/NNP ,/, the/DT university/NN 's/POS vice/NN president/NN of/IN research/NN ./.
Ciba-Geigy/NNP is/VBZ a/DT Swiss/JJ pharmaceutical/JJ company/NN and/CC Chiron/NNP is/VBZ based/VBN *-1/-NONE- in/IN Emeryville/NNP ,/, Calif/NNP ./.
In/IN a/DT statement/NN ,/, Jacques-Francois/NNP Martin/NNP ,/, director/NN general/NN of/IN Merieux/NNP ,/, said/VBD 0/-NONE- the/DT French/JJ company/NN is/VBZ still/RB determined/VBN *-1/-NONE- to/TO acquire/VB Connaught/NNP ./.
While/IN he/PRP did/VBD n't/RB comment/NN directly/RB on/IN the/DT pact/NN between/IN Ciba-Geigy/NNP and/CC the/DT university/NN ,/, he/PRP said/VBD 0/-NONE- Merieux/NNP can/MD transfer/VB new/JJ products/NNS and/CC technologies/NNS to/TO Connaught/NNP more/RBR rapidly/RB than/IN other/JJ companies/NNS ``/`` not/RB currently/RB producing/VBG and/CC marketing/VBG vaccines/NNS -LCB-/-LRB- who/WP -RCB-/-RRB- *T*-2/-NONE- can/MD only/RB promise/VB this/DT for/IN some/DT .../: years/NNS in/IN the/DT future/NN ./. ''/''
In/IN national/JJ over-the-counter/JJ trading/NN yesterday/NN ,/, Connaught/NNP closed/VBD at/IN $/$ 28.625/CD *U*/-NONE- ,/, up/IN $/$ 1.25/CD *U*/-NONE- ./.

